Search results for: 'qualitative diseas analyst research'
- Related search terms
- Research Data on Steel Chain Imports Across the World to Indian market
- diseas solution market research methodology greater china
- diseas destructive services market research
- research ar analysis for transformation health growth consisting
- research ar analysi for transformation health growth consisting
-
24 Feb 2016  |  North America  |  Market Research
US Autoimmune Disease Diagnostics Market, Forecast to 2020
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...
$1,500.00 -
19 Dec 2022  |  North America  |  Market Research
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities
Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem
Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...
$2,450.00 -
05 Oct 2018  |  North America  |  Market Research
US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth
Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...
$1,500.00 -
06 Oct 2021  |  North America  |  Market Research
US Chronic Disease Management Growth Opportunities
Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management
The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...
$4,950.00 -
15 Dec 2023  |  North America  |  Market Research
US Life Sciences Research Tools Growth Opportunities
Innovative Financing in Cancer Moonshot and ARPA-H Strengthens Biomedical and Health Research
Frost & Sullivan s global IoT industry predictions for calendar 2024 are the result of aggregated input from Frost & Sullivan regional IoT and Edge research teams. Research analysts input leverages the extensive Frost & Sullivan knowledge base, as well as primary and secondary research. This Top 10 Growth Opportunities report reflects the hot ...
$2,450.00 -
13 Apr 2022  |  North America  |  Market Research
US Life Sciences Research Tools Growth Opportunities
Transformational Growth with the Proposed Launch of ARPA-H to Spur Investments across High-risk, High-reward Translational Research Projects, Foster Breakthroughs, and Facilitate Equitable Access to Care
The US life sciences research tools market encompasses analytical tools, instruments, consumables, reagents, and services (e.g., X-rays and sample preparation). Tools include laboratory automation and technologies that provide molecular insight into disease mechanisms and enable novel therapeutic and medical device development to improve human heal...
$2,450.00 -
26 Sep 2019  |  North America  |  Market Research
US DoD C4ISR Market, Forecast to 2024
Continuing Standardization and Qualitative Improvement Efforts by Expanding and Adopting More Innovative Commercial Technology
This research service focuses on the US Department of Defense (DoD) command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) budget spending. An analysis of research, development, test, and evaluation (RDT&E); procurement; operations and maintenance (O&M); and a variety of services are included in this stu...
$4,950.00 -
26 Aug 2020  |  North America  |  Market Research
Assessment of the US DoD C4ISR Market, Forecast to 2025
DoD is Continuing Standardization and Qualitative Improvement Efforts by Expanding and Adopting More Innovative Commercial IT Technology
This research service focuses on the US Department of Defense (DoD) command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) budget spending. An analysis of research, development, test, and evaluation (RDT&E); procurement; operations and maintenance (O&M); and a variety of other services are also presented...
$4,950.00 -
17 Jan 2020  |  North America  |  Market Research
US Defense Science and Technology Research Market, Forecast to 2024
Research, Development, Testing, and Evaluation is Key to Sustaining the Most Powerful Military in the World
The Department of Defense (DoD) relies on the technological superiority of its weapon systems and armed forces to protect US interests at home and abroad. This technological superiority is being challenged by new and evolving threats constantly being developed by potential US adversaries. To counteract these challenges, DoD’s science and technology...
$4,950.00 -
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00